TickerFactsScreenerDevelopers

Corvus Pharmaceuticals, Inc. (CRVS) — Net Income

Annual figures by fiscal year, from SEC filings.

2015: -$31.34M2016: -$36.38M2017: -$55.66M2018: -$46.94M2019: -$46.67M2020: -$6.00M2021: -$43.24M2022: -$41.31M2023: -$27.03M2024: -$62.29M2025: -$15.28M-$15.28M
2015Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$15.28M+75.5%
2024-$62.29M-130.5%
2023-$27.03M+34.6%
2022-$41.31M+4.5%
2021-$43.24M-621.3%
2020-$6.00M+87.2%
2019-$46.67M+0.6%
2018-$46.94M+15.7%
2017-$55.66M-53.0%
2016-$36.38M-16.1%
2015-$31.34M—